Skip to main content
Filing year 2023

EPIDEMIOLOGIC SOLUTIONS CORPORATION

Westlake, Louisiana·EIN 85-2306010·NTEE H80 · Medical Research·501(c)(3)
Total revenue
$22k
Total assets
$574k
Total expenses
$469k
Reported officers
1
Mission

MOST SIGNIFICANTLY, RESEARCH TO DEVELOP TREATMENTS FOR A RANGE OF DISEASES, PRINCIPALLY FOCUSED ON EXTRACORPOREAL METHOD TREATSBLOOD-BORNE,NEUROLOGIC AND INFECTIOUS DISEASES, BY REMOVING BODILY FLUIDS IN A CONTINUOUS FASHION LIKE DIALYSIS, OR IN A BATCH PROCESS.

Reported officers (all unpaid)

No paid executives reported in 2023. EPIDEMIOLOGIC SOLUTIONS CORPORATION reported 1 unpaid officer or board member on its 990.

CEO
Sector benchmark

What Medical Research executives earn

EPIDEMIOLOGIC SOLUTIONS CORPORATION reported no executive compensation in its latest filing. For context, the highest-paid executive at a comparable medical research organization nationwide earns a median of $120,264.

25th percentile
$48k
Median
$120,264
75th percentile
$252k
90th percentile
$466k

These are medical research sector-wide figures, not this organization's reported pay. Based on 1,118 organizations across 1,118 filings (2020 – 2024).

See full Medical Research compensation data
FAQ

Common questions about EPIDEMIOLOGIC SOLUTIONS CORPORATION

What are EPIDEMIOLOGIC SOLUTIONS CORPORATION's revenue and expenses?

In 2023, EPIDEMIOLOGIC SOLUTIONS CORPORATION reported $22k in total revenue and $469k in total expenses on its IRS Form 990.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.